STRS Ohio’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,579
| Closed | -$104K | – | 2168 |
|
|
2026
Q1 | $104K | Sell |
2,579
-3
| -0.1% | -$65 | ﹤0.01% | 1765 |
|
|
2025
Q4 | $64.9K | Buy |
2,582
+4
| +0.2% | +$94 | ﹤0.01% | 1915 |
|
|
2025
Q3 | $58.3K | Buy |
2,578
+1
| +0% | +$23 | ﹤0.01% | 1978 |
|
|
2025
Q2 | $44.6K | Buy |
+2,577
| New | +$47.7K | ﹤0.01% | 2045 |
|
|
2024
Q3 | – | Sell |
-17,650
| Closed | -$677K | – | 1969 |
|
|
2024
Q2 | $677K | Buy |
+17,650
| New | +$799K | ﹤0.01% | 1038 |
|
|
2023
Q3 | – | Sell |
-7,521
| Closed | -$685K | – | 1938 |
|
|
2023
Q2 | $685K | Sell |
7,521
-4,679
| -38% | -$404K | ﹤0.01% | 1100 |
|
|
2023
Q1 | $804K | Buy |
12,200
+1,800
| +17% | +$104K | ﹤0.01% | 1039 |
|
|
2022
Q4 | $537K | Sell |
10,400
-2,500
| -19% | -$133K | ﹤0.01% | 1286 |
|
|
2022
Q3 | $881K | Buy |
12,900
+3,700
| +40% | +$219K | ﹤0.01% | 977 |
|
|
2022
Q2 | $416K | Buy |
9,200
+6,000
| +188% | +$274K | ﹤0.01% | 1409 |
|
|
2022
Q1 | $162K | Buy |
3,200
+100
| +3% | +$4.42K | ﹤0.01% | 1758 |
|
|
2021
Q4 | $146K | Sell |
3,100
-21,200
| -87% | -$835K | ﹤0.01% | 1813 |
|
|
2021
Q3 | $800K | Buy |
24,300
+8,300
| +52% | +$466K | ﹤0.01% | 1259 |
|
|
2021
Q2 | $1.01M | Buy |
+16,000
| New | +$826K | ﹤0.01% | 1159 |
|
|
2021
Q1 | – | Sell |
-3,400
| Closed | -$194K | – | 2173 |
|
|
2020
Q4 | $194K | Buy |
+3,400
| New | +$144K | ﹤0.01% | 1749 |
|
|
2020
Q3 | – | Sell |
-9,800
| Closed | -$320K | – | 2189 |
|
|
2020
Q2 | $320K | Sell |
9,800
-21,300
| -68% | -$684K | ﹤0.01% | 1509 |
|
|
2020
Q1 | $833K | Hold |
31,100
| – | – | ﹤0.01% | 802 |
|
|
2019
Q4 | $952K | Sell |
31,100
-2,700
| -8% | -$74.7K | ﹤0.01% | 940 |
|
|
2019
Q3 | $814K | Buy |
+33,800
| New | +$930K | ﹤0.01% | 897 |
|
|
2018
Q2 | – | Sell |
-3,100
| Closed | -$68K | – | 2117 |
|
|
2018
Q1 | $68K | Hold |
3,100
| – | – | ﹤0.01% | 1683 |
|
|
2017
Q4 | $67K | Buy |
+3,100
| New | +$45.6K | ﹤0.01% | 1696 |
|
Other funds holding APLS
STRS Ohio's APLS Position: Q2 2026 in Review
STRS Ohio sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 2,579 shares — an estimated $104K sold.
STRS Ohio first reported a position in APLS in Q4 2017 and held it in 21 quarters. The position peaked at $1.01M in Q2 2021. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- STRS Ohio reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- STRS Ohio sold 2,579 Apellis Pharmaceuticals shares in Q2 2026, an estimated $104K.
- STRS Ohio first reported a position in Apellis Pharmaceuticals in Q4 2017 and held it in 21 quarters.
- STRS Ohio's Apellis Pharmaceuticals position peaked at $1.01M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.